Women's self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria.
Melissa StillmanOnikepe O OwolabiAdesegun Olayiwola FatusiAkanni Ibukun AkinyemiAmanda L BerryTemitope Peter ErinfolamiOlalekan Seun OlagunjuHeini VäisänenAkinrinola BankolePublished in: BMJ open (2020)
Drug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion.
Keyphrases
- polycystic ovary syndrome
- healthcare
- mental health
- public health
- pregnancy outcomes
- randomized controlled trial
- systematic review
- cervical cancer screening
- breast cancer risk
- type diabetes
- insulin resistance
- health information
- drug induced
- metabolic syndrome
- emergency department
- adipose tissue
- pregnant women
- health promotion
- social media
- human health